These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31316988)

  • 1. Cell Line Derived Xenograft Mouse Models Are a Suitable
    Georges LMC; De Wever O; Galván JA; Dawson H; Lugli A; Demetter P; Zlobec I
    Front Med (Lausanne); 2019; 6():139. PubMed ID: 31316988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5.
    Sadek SA; A Rehim DM; Fatima S
    Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between Peritumoral and Intratumoral Budding in Colorectal Cancer.
    Pyo JS; Choi JE; Kim NY; Min KW; Kang DW
    Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of tumor budding in colorectal carcinoma: correlation with β-catenin nuclear expression.
    El-Gendi S; Al-Gendi A
    J Egypt Natl Canc Inst; 2011 Mar; 23(1):1-9. PubMed ID: 22099930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining.
    Blank A; Schenker C; Dawson H; Beldi G; Zlobec I; Lugli A
    Front Med (Lausanne); 2019; 6():247. PubMed ID: 31737639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of peritumoral and intratumoral budding in esophageal adenocarcinomas.
    Thies S; Guldener L; Slotta-Huspenina J; Zlobec I; Koelzer VH; Lugli A; Kröll D; Seiler CA; Feith M; Langer R
    Hum Pathol; 2016 Jun; 52():1-8. PubMed ID: 26980046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive assessment of tumour budding by cytokeratin staining in colorectal cancer.
    Rieger G; Koelzer VH; Dawson HE; Berger MD; Hädrich M; Inderbitzin D; Lugli A; Zlobec I
    Histopathology; 2017 Jun; 70(7):1044-1051. PubMed ID: 28061021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HtrA3 stromal expression is correlated with tumor budding in stage II colorectal cancer.
    Forse CL; Rahimi M; Diamandis EP; Assarzadegan N; Dawson H; Grin A; Kennedy E; O'Connor B; Messenger DE; Riddell RH; Kirsch R; Karagiannis GS
    Exp Mol Pathol; 2017 Aug; 103(1):94-100. PubMed ID: 28716573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-expression of cytokeratin and vimentin in colorectal cancer highlights a subset of tumor buds and an atypical cancer-associated stroma.
    Meyer SN; Galván JA; Zahnd S; Sokol L; Dawson H; Lugli A; Zlobec I
    Hum Pathol; 2019 May; 87():18-27. PubMed ID: 30794893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor budding at the invasive front of colorectal cancer may not be associated with the epithelial-mesenchymal transition.
    Yamada N; Sugai T; Eizuka M; Tsuchida K; Sugimoto R; Mue Y; Suzuki M; Osakabe M; Uesugi N; Ishida K; Otsuka K; Matsumoto T
    Hum Pathol; 2017 Feb; 60():151-159. PubMed ID: 27836787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer.
    Galván JA; Zlobec I; Wartenberg M; Lugli A; Gloor B; Perren A; Karamitopoulou E
    Br J Cancer; 2015 Jun; 112(12):1944-50. PubMed ID: 25989272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-type tumor budding phenotype and is an independent prognostic factor in surgically resected pancreatic ductal adenocarcinoma.
    Wartenberg M; Zlobec I; Perren A; Koelzer VH; Gloor B; Lugli A; Karamitopoulou E
    Oncotarget; 2015 Feb; 6(6):4190-201. PubMed ID: 25669968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical-based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial-mesenchymal transition.
    Banias L; Jung I; Bara T; Fulop Z; Simu P; Simu I; Satala C; Gurzu S
    Oncol Lett; 2020 Feb; 19(2):1487-1495. PubMed ID: 31966075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.
    Galván JA; Helbling M; Koelzer VH; Tschan MP; Berger MD; Hädrich M; Schnüriger B; Karamitopoulou E; Dawson H; Inderbitzin D; Lugli A; Zlobec I
    Oncotarget; 2015 Jan; 6(2):874-85. PubMed ID: 25528769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of tumor budding, desmoplastic reaction, and lymphocytic infiltration in patients with gastric adenocarcinoma.
    Yavuz A; Simsek K; Alpsoy A; Altunay B; Gedik EO; Unal B; Bassorgun CI; Tatli AM; Elpek GO
    World J Gastrointest Pathophysiol; 2024 Apr; 15(1):91237. PubMed ID: 38682027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.
    Lugli A; Vlajnic T; Giger O; Karamitopoulou E; Patsouris ES; Peros G; Terracciano LM; Zlobec I
    Hum Pathol; 2011 Dec; 42(12):1833-40. PubMed ID: 21664647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Implications of Intratumoral Budding in Colorectal Cancer: Detailed Analysis Based on Tumor-Infiltrating Lymphocytes.
    Pyo JS; Choi JE; Kim NY; Min KW; Kang DW
    J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Budding and Poorly Differentiated Clusters in Small Intestinal Adenocarcinoma.
    Jun SY; Chung JY; Yoon N; Jung ES; Oh YH; Hong SM
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32781596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scutellaria barbata D. Don inhibits colorectal cancer growth via suppression of Wnt/β-catenin signaling pathway.
    Wei LH; Lin JM; Chu JF; Chen HW; Li QY; Peng J
    Chin J Integr Med; 2017 Nov; 23(11):858-863. PubMed ID: 29080197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.
    Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W
    J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.